Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

NCT00259038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive
Heart Decompensation
Left Ventricular Failure
Myocardiopathies
Systolic or Diastolic Left Ventricular Dysfunction

Interventions

DRUG: Carperitide
DRUG: Placebo

Sponsor

Daiichi Sankyo